查詢結果分析
來源資料
相關文獻
- Pulmonary Kaposi's Sarcoma in a Patient Infected with Human Immunodeficiency Virus 1: Successful Treatment with Paclitaxel
- 臺灣紅豆杉天然母樹枝葉紫杉醇類含量的變異與選種價值
- 母親為HIV感染者所生嬰兒的評估、追蹤與治療
- 人類免疫缺乏病毒感染的脂質代謝異常
- 經針刺感染愛滋病毒「人類免疫缺乏病毒」
- 紫杉醇對婦女癌症之治療
- 人類免疫缺乏病毒感染病患流行病學及醫護人員照護意願調查
- Oral Manifestations of Human Immunodeficiency Virus-Infected Patients in Taiwan
- 護理人員之愛滋病照護知識、態度及行為趨向之探討
- 太平洋紫杉醇Taxol臨床運用與護理
頁籤選單縮合
題 名 | Pulmonary Kaposi's Sarcoma in a Patient Infected with Human Immunodeficiency Virus 1: Successful Treatment with Paclitaxel=肺部卡波西氏肉瘤發生在人類免疫缺乏病毒感染者身上--成功以紫杉醇治療 |
---|---|
作 者 | 陳宗家; 林俊良; 李鼎專; 賴銘淙; 曾婷玉; | 書刊名 | 內科學誌 |
卷 期 | 29:3 2018.06[民107.06] |
頁 次 | 頁175-179 |
分類號 | 415.46 |
關鍵詞 | 肺部卡波西氏肉瘤; 人類免疫缺乏病毒; 紫杉醇; Pulmonary Kaposi's sarcoma; HIV; Paclitaxel; |
語 文 | 英文(English) |
中文摘要 | 我們在此報告一位罹患肺部卡波西氏肉瘤的愛滋病患者,經診斷後以較高劑量(200 mg/ m^2)的紫杉醇治療,兩周一次共治療三次後痊癒,經追蹤沒有復發的個案報告。 |
英文摘要 | The incidence of Kaposi's sarcoma on HIV-1-infected patients declined in the post-antiretroviral therapy (ART) era. Furthermore, pulmonary Kaposi's sarcoma constituted a smaller proportion of all Kaposi's sarcoma patients. The treatment of Kaposi's sarcoma depends on the disease severity. Chemotherapy with ART is crucial in the treatment of pulmonary Kaposi's sarcoma. Moreover, paclitaxel and pegylated liposomal doxorubicin are used for the treatment of this disease, and their effects are comparable. Various doses and schedules were adopted by different clinicians. In this study, we present a patient diagnosed with pulmonary Kaposi's sarcoma, treated with high dose of paclitaxel (200 mg/m^2, every 2 weeks) for this disease entity and achieved an excellent outcome. |
本系統中英文摘要資訊取自各篇刊載內容。